Life Sciences Tools & Services · NYSE
TMOThermo Fisher Scientific Inc.
- Last close
- $700.22 +0.1%
- 52-week range
- $435.27 to $727.56
- Market cap
- $259B
- Next earnings
- Not scheduled
Fiscal 2025 at a glance
Stock price
Valuation vs its own 10 years
Above its 10-year median on all 4 multiples
Where each multiple sits today inside its own range since 2016, measured at every quarter end. The thin tick is the median.
Key statistics
Trailing 12 months unless noted, through the quarter ending 2026-09-26. Every figure carries its unit.
Valuation
- P/E
- 36.9x
- Earnings yield
- 2.7%
- Price / sales
- 5.5x
- Price / book
- 4.7x
- Price / operating cash flow
- 27.8x
- EV / EBITDA
- 30.4x
- EV / sales
- 6.2x
- Free cash flow yield
- 2.9%
Profitability
- Gross margin
- n/aNot reported
- Operating margin
- 17.9%
- Net margin
- 14.9%
- Return on equity
- 12.9%
- Return on capital
- 8.0%
Growth per year
- Revenue, 3 years
- -0.3%
- Revenue, 5 years
- +6.7%
- Revenue, 9 years
- +10.4%
- EPS, 3 years
- +0.2%
Balance sheet
- Cash and investments
- $6.06B
- Total debt
- $41.4B
- Net cash
- -$35.3B
- Debt / equity
- 0.76x
- Current ratio
- 1.81x
Shares and dividend
- Shares outstanding
- 371M
- Share count, 5 years
- -5.3%
- Beta, 1 year
- 0.69
- Dividend yield
- 0.3%
- Dividend per share, TTM
- $1.84
- Payout ratio
- 9.5%
Ten years of the business
Last 40 quarters, fiscal 2016 to 2025 and after. Hover a bar for its quarter.
Fiscal years 2016 to 2025.
Where the revenue comes from
Services went from 36% to 42% of revenue in 3 years
Share of revenue by product line, fiscal 2022 to 2025, as reported in the 10-K.
| Product line | Revenue | Share | vs FY24 |
|---|---|---|---|
| Consumables | $18.7B | 41.9% | +6% |
| Services | $18.6B | 41.7% | +4% |
| Instruments | $7.30B | 16.4% | -2% |
Life Sciences Tools & Services peers
The largest names in the same industry that we cover, all in US dollars. The last column applies the same history test to each peer.
| Company | Market cap | Revenue growth | Operating margin | P/E | P/S | P/E vs own history |
|---|---|---|---|---|---|---|
| TMO Thermo Fisher Scientific Inc. | $259B | +8% | 17.9% | 36.9x | 5.5x | 88th percentile |
| A Agilent Technologies, Inc. | $49.0B | +9% | 22.2% | 34.2x | 6.7x | 64th percentile |
| WAT Waters Corp | $45.2B | +81% | 4.7% | 198x | 8.1x | 90th percentile |
| IQV Iqvia Holdings Inc. | $43.7B | +9% | 12.8% | 32.2x | 2.5x | 38th percentile |
| MTD Mettler Toledo International Inc/ | $34.6B | +7% | n/a | 37.7x | 8.2x | 58th percentile |
| ILMN Illumina, Inc. | $31.3B | +6% | 21.1% | 35.6x | 6.9x | 25th percentile |
The company
- Sector
- Health Care
- Industry
- Life Sciences Tools & Services
- Employees
- 67,816 (as of 2023)
- Founded
- 2006
- Headquarters
- Waltham, MA
- Fiscal year ends
- December
- Website
- thermofisher.com
What it does
Thermo Fisher Scientific Inc. is an American life science and clinical research company. It is a global supplier of analytical instruments, clinical development solutions, specialty diagnostics, laboratory, pharmaceutical and biotechnology services. Based in Waltham, Massachusetts, Thermo Fisher was formed through the merger of Thermo Electron and Fisher Scientific in 2006.
Description from Wikipedia (CC BY-SA).
Around the numbers
What the rest of EdgeStacker knows about TMO.